Dariohealth announces $25.6m private placement positioning the company to execute on strategy aiming to reach operational cash flow positive run rate by the end of 2025

Significant participation from existing shareholders and accredited healthcare investors, which the company believes underscores confidence in its strategy financing supports execution of long-term growth initiatives focused on high-margin, scalable recurring revenues across b2b (business-to-business) and pharma channels new york , jan. 21, 2025 /prnewswire/ -- dariohealth corp. (nasdaq: drio) ("dario" or the "company"), a prominent leader in the global digital health industry, announced today the successful closing of a $25.6 million private placement of convertible preferred stock, priced in accordance with nasdaq market rules. the majority of the funds were secured from existing shareholders, with the remainder contributed by a network of leading accredited healthcare investors and executives from the healthcare sector.
DRIO Ratings Summary
DRIO Quant Ranking